Pediatric Nephrology

, Volume 32, Issue 7, pp 1201–1209 | Cite as

The ISKDC classification and a new semiquantitative classification for predicting outcomes of Henoch–Schönlein purpura nephritis

  • Mikael KoskelaEmail author
  • Elisa Ylinen
  • Elli-Maija Ukonmaanaho
  • Helena Autio-Harmainen
  • Päivi Heikkilä
  • Jouko Lohi
  • Outi Jauhola
  • Jaana Ronkainen
  • Timo Jahnukainen
  • Matti Nuutinen
Original Article



Histological findings from primary kidney biopsies were correlated with patient outcomes in a national cohort of paediatric Henoch–Schönlein nephritis (HSN) patients.


Primary kidney biopsies from 53 HSN patients were re-evaluated using the ISKDC (International Study of Kidney Disease in Children) classification and a modified semiquantitative classification (SQC) that scores renal findings and also takes into account activity, chronicity and tubulointerstitial indices. The ISKDC and SQC classifications were evaluated comparatively in four outcome groups: no signs of renal disease (outcome A, n = 27), minor urinary abnormalities (outcome B, n = 18), active renal disease (outcome C, n = 3) and renal insufficiency, end-stage renal disease or succumbed due to HSN (outcome D, n = 5). For the receiver operating characteristic and logistic regression analyses, outcomes A and B were considered to be favourable and outcomes C and D to be unfavourable. The median follow-up time was 7.3 years.


The patients with an unfavourable outcome (C and D), considered together due to low patient numbers, had significantly higher total biopsy SQC scores and activity indices than those who had a favourable one (groups A and B). The chronicity and tubulointerstitial indices differed significantly only between group C + D and group A. The difference in areas under the curve between the total biopsy SQC scores and ISKDC findings was 0.15 [p = 0.04, normal-based 95% confidence interval (CI) 0.007–0.29, bias-controlled 95% CI −0.004 to 0.28].


Our results suggest that the modified SQC is more sensitive than ISKDC classification for predicting the outcome in HSN cases.


Children Glomerulonephritis Histology Renal biopsy Semiquantitative Vasculitis 



The authors wish to thank Jesper Kivelä and Mitja Lääperi for assistance in the statistical analyses.

Compliance with ethical standards


This work was supported by a grant to M.K. from the Alma and K.A. Snellman Foundation, Oulu, Finland and from the Foundation of Paediatric Research and salary to M.K. from Competitive State Research Financing of the Expert Responsibility area of Oulu University Hospital.

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

467_2017_3608_MOESM1_ESM.pdf (360 kb)
Table S1 (PDF 360 kb)


  1. 1.
    Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR (2002) Incidence of Henoch–SchonleinSchönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 360:1197–1202CrossRefPubMedGoogle Scholar
  2. 2.
    Saulsbury FT (2007) Clinical update: Henoch–SchonleinSchönlein purpura. Lancet 369:976–978CrossRefPubMedGoogle Scholar
  3. 3.
    Narchi H (2005) Risk of long term renal impairment and duration of follow up recommended for Henoch–SchonleinSchönlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 90:916–920CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Davin JC (2011) Henoch–SchonleinSchönlein purpura nephritis: pathophysiology, treatment, and future strategy. Clin J Am Soc Nephrol 6:679–689CrossRefPubMedGoogle Scholar
  5. 5.
    Counahan R, Winterborn MH, White RH, Heaton JM, Meadow SR, Bluett NH, Swetschin H, Cameron JS, Chantler C (1977) Prognosis of Henoch–SchonleinSchönlein nephritis in children. Br Med J 2:11–14CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Davin JC, Coppo R (2013) Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch–SchonleinSchönlein purpura nephritis. Pediatr Nephrol 28:1897–1903CrossRefPubMedGoogle Scholar
  7. 7.
    Ronkainen J, Ala-Houhala M, Autio-Harmainen H, Jahnukainen T, Koskimies O, Merenmies J, Mustonen J, Ormala T, Turtinen J, Nuutinen M (2006) Long-term outcome 19 years after childhood IgA nephritis: a retrospective cohort study. Pediatr Nephrol 21:1266–1273CrossRefPubMedGoogle Scholar
  8. 8.
    Jauhola O, Ronkainen J, Autio-Harmainen H, Koskimies O, Ala-Houhala M, Arikoski P, Holtta T, Jahnukainen T, Rajantie J, Ormala T, Nuutinen M (2011) Cyclosporine A vs. methylprednisolone for Henoch–SchonleinSchönlein nephritis: a randomized trial. Pediatr Nephrol 26:2159–2166CrossRefPubMedGoogle Scholar
  9. 9.
    Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Levey AS, Stevens LA, Schmid CH, Zhang YL, 3rd Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1–150.
  12. 12.
    Goldstein AR, White RH, Akuse R, Chantler C (1992) Long-term follow-up of childhood Henoch–SchonleinSchönlein nephritis. Lancet 339:280–282CrossRefPubMedGoogle Scholar
  13. 13.
    Ronkainen J, Nuutinen M, Koskimies O (2002) The adult kidney 24 years after childhood purpura: a retrospective cohort study. Lancet 360:666–670CrossRefPubMedGoogle Scholar
  14. 14.
    Nuutinen M, Lautala P, Remes M, Uhari M (2000) Nephrectomy in severe hypertension. Clin Nephrol 54:342–346PubMedGoogle Scholar
  15. 15.
    Pepe MS, Longton G, Janes H (2009) Estimation and comparison of receiver operating characteristic curves. Stata J 9:1–16PubMedPubMedCentralGoogle Scholar
  16. 16.
    Clayton P. CUTPT: Stata module for empirical estimation of cutpoint for a diagnostic test. https://Ideas.Repec.Org/C/Boc/Bocode/S457719.Html. Accessed May 2016
  17. 17.
    Cicchetti D (1994) Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess 6:284–290CrossRefGoogle Scholar
  18. 18.
    Edstrom Halling S, Soderberg MP, Berg UB (2010) Predictors of outcome in Henoch–SchonleinSchönlein nephritis. Pediatr Nephrol 25:1101–1108CrossRefPubMedGoogle Scholar
  19. 19.
    Ronkainen J, Ala-Houhala M, Huttunen NP, Jahnukainen T, Koskimies O, Ormala T, Nuutinen M (2003) Outcome of Henoch–SchonleinSchönlein nephritis with nephrotic-range proteinuria. Clin Nephrol 60:80–84CrossRefPubMedGoogle Scholar
  20. 20.
    Foster BJ, Bernard C, Drummond KN, Sharma AK (2000) Effective therapy for severe Henoch–SchonleinSchönlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. J Pediatr 136:370–375CrossRefPubMedGoogle Scholar
  21. 21.
    Lim BJ, Shin JI, Choi SE, Rhim H, Lee JS, Kim PK, Jeong HJ, Kim JH (2016) The significance of tubulointerstitial lesions in childhood Henoch–SchonleinSchönlein nephritis. Pediatr Nephrol 31:2087–2093CrossRefPubMedGoogle Scholar
  22. 22.
    Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D (2002) Henoch–SchonleinSchönlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 13:1271–1278CrossRefPubMedGoogle Scholar
  23. 23.
    Wakaki H, Ishikura K, Hataya H, Hamasaki Y, Sakai T, Yata N, Kaneko T, Honda M (2011) Henoch–SchonleinSchönlein purpura nephritis with nephrotic state in children: predictors of poor outcomes. Pediatr Nephrol 26:921–925CrossRefPubMedGoogle Scholar
  24. 24.
    Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, Locatelli F, Cagnoli L (2006) Predictors of outcome in Henoch–SchonleinSchönlein nephritis in children and adults. Am J Kidney Dis 47:993–1003CrossRefPubMedGoogle Scholar
  25. 25.
    Niaudet P, Habib R (1998) Methylprednisolone pulse therapy in the treatment of severe forms of Henoch–SchonleinSchönlein purpura nephritis. Pediatr Nephrol 12:238–243CrossRefPubMedGoogle Scholar
  26. 26.
    Kawasaki Y, Suzuki J, Suzuki H (2004) Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch–SchonleinSchönlein nephritis: a clinical and histopathological study. Nephrol Dial Transplant 19:858–864CrossRefPubMedGoogle Scholar
  27. 27.
    Szeto CC, Choi PC, To KF, Li PK, Hui J, Chow KM, Leung CB, Lui SF, Mac-Moune Lai F (2001) Grading of acute and chronic renal lesions in Henoch–SchonleinSchönlein purpura. Mod Pathol 14:635–640CrossRefPubMedGoogle Scholar
  28. 28.
    Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D’Agati V, D’Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H (2009) The oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 76:546–556CrossRefGoogle Scholar
  29. 29.
    Pohl M (2015) Henoch–SchonleinSchönlein purpura nephritis. Pediatr Nephrol 30:245–252CrossRefPubMedGoogle Scholar
  30. 30.
    Kim CH, Lim BJ, Bae YS, Kwon YE, Kim YL, Nam KH, Park KS, An SY, Koo HM, Doh FM, Lee MJ, Oh HJ, Yoo TH, Kang SW, Choi KH, Jeong HJ, Han SH (2014) Using the oxford classification of IgA nephropathy to predict long-term outcomes of Henoch–SchonleinSchönlein purpura nephritis in adults. Mod Pathol 27:972–982CrossRefPubMedGoogle Scholar
  31. 31.
    Davin JC, Ten Berge IJ, Weening JJ (2001) What is the difference between IgA nephropathy and Henoch–SchonleinSchönlein purpura nephritis? Kidney Int 59:823–834CrossRefPubMedGoogle Scholar
  32. 32.
    Scharer K, Krmar R, Querfeld U, Ruder H, Waldherr R, Schaefer F (1999) Clinical outcome of Henoch–SchonleinSchönlein purpura nephritis in children. Pediatr Nephrol 13:816–823CrossRefPubMedGoogle Scholar
  33. 33.
    Davin JC, Coppo R (2014) Henoch–SchonleinSchönlein purpura nephritis in children. Nat Rev Nephrol 10:563–573CrossRefPubMedGoogle Scholar
  34. 34.
    Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J, Ormala T, Turtinen J, Nuutinen M (2006) Early prednisone therapy in Henoch–SchonleinSchönlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr 149:241–247CrossRefPubMedGoogle Scholar
  35. 35.
    Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Holtta T, Jahnukainen T, Rajantie J, Ormala T, Turtinen J, Nuutinen M (2010) Renal manifestations of Henoch–SchonleinSchönlein purpura in a 6-month prospective study of 223 children. Arch Dis Child 95:877–882CrossRefPubMedGoogle Scholar
  36. 36.
    Vittinghoff E, McCulloch CE (2007) Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 165:710–718CrossRefPubMedGoogle Scholar

Copyright information

© IPNA 2017

Authors and Affiliations

  • Mikael Koskela
    • 1
    Email author
  • Elisa Ylinen
    • 1
  • Elli-Maija Ukonmaanaho
    • 2
  • Helena Autio-Harmainen
    • 3
  • Päivi Heikkilä
    • 4
  • Jouko Lohi
    • 4
  • Outi Jauhola
    • 5
  • Jaana Ronkainen
    • 6
  • Timo Jahnukainen
    • 1
  • Matti Nuutinen
    • 2
    • 7
  1. 1.Department of Pediatric Nephrology and TransplantationChildren’s Hospital, Helsinki University Hospital and University of HelsinkiHelsinkiFinland
  2. 2.Department of Children and AdolescentsOulu University HospitalOuluFinland
  3. 3.Medical Research Center Oulu and Department of PathologyOulu University HospitalOuluFinland
  4. 4.Department of PathologyHelsinki University HospitalHelsinkiFinland
  5. 5.Department of PediatricsHyvinkää HospitalHyvinkääFinland
  6. 6.Oulu City Health Care CentreOuluFinland
  7. 7.Research Unit for Pediatrics, Dermatology, Clinical Genetics, Obstetrics and Gynecology (PEDEGO Research Unit)Medical Reasearch Center Oulu (MRC Oulu)OuluFinland

Personalised recommendations